MedCu Technologies, an Israeli wound-care startup, won an innovation award this week at the Medtech Strategist Innovation Summit in San Diego after showcasing copper-infused dressings designed to speed healing and reduce infection risk, the company said. The recognition followed MedCu’s participation in the MedTech Innovator accelerator and was based on criteria including technological innovation, go-to-market strategy, product quality, commercial potential, and expected impact on healthcare systems.
According to MedCu, its dressings create an active antimicrobial environment to treat hard-to-heal wounds, including diabetic and venous ulcers, pressure injuries, and burns. The company said its products are commercially available worldwide, including across Israel’s major HMOs and hospitals.
What the award recognizes
Organizers highlighted solutions with strong clinical promise and clear commercialization paths. MedCu’s copper-based platform aims to reduce infection burden while improving healing times in community and hospital settings.
The company said evaluators considered innovation, scalability, and health-system value. MedCu added that the award underscores Israel’s position in global medical-device innovation.
MedCu’s technology has been profiled in prior clinical and industry reports in Israel, where copper-based wound dressings have shown effectiveness in diabetic foot ulcers and other complex wounds. The startup is expanding its international distribution and providing clinician training to facilitate adoption.
Israeli medtech continues to draw strong global attention, with dozens of companies exhibiting this month at major European and US industry gatherings. Studies have reported copper-infused dressings developed in Israel performing on par with standard therapies in diabetic wound care, while local research groups advance new wound-healing materials for burns and chronic ulcers.
“In these challenging times, it is a tremendous honor for us as an Israeli company to receive international recognition for the copper-based dressings we developed,” MedCu CEO Danny Lustiger said. “This award highlights the strength of Israeli innovation and its ability to positively impact global healthcare.”